SOPH
SOPHiA GENETICS S.A.
NASDAQ · Healthcare · Medical - Healthcare Information Services · CH
$8.16
−1.69%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 86.2M | 77.3M | 65.2M | 62.4M | 47.6M |
| Cost of Revenue | 28.8M | 29.5M | 21.2M | 19.5M | 16.3M |
| Gross Profit | 57.4M | 47.8M | 43.9M | 42.9M | 31.3M |
| Operating Expenses | |||||
| R&D Expense | 37.7M | 33.6M | 34.4M | 37.0M | 35.4M |
| SG&A Expense | 95.7M | 85.2M | 76.3M | 81.7M | 84.1M |
| General & Admin Expense | 42.9M | — | 47.0M | 53.3M | 55.8M |
| Selling & Marketing Expense | 28.7M | — | 29.4M | 28.4M | 28.3M |
| Other Expenses | (2.8M) | — | (183.0K) | (954.0K) | (377.0K) |
| Total Operating Expenses | 130.7M | 118.7M | 110.5M | 117.7M | 119.1M |
| Cost and Expenses | 159.4M | 148.2M | 131.7M | 137.2M | 135.4M |
| Operating Income (EBIT) | (73.2M) | (70.9M) | (66.6M) | (74.8M) | (87.8M) |
| Non-Operating | |||||
| Interest Income | 1.5M | 1.9M | 3.4M | 4.5M | 1.3M |
| Interest Expense | 6.6M | 4.6M | 1.9M | 588.0K | 639.0K |
| Net Interest Income | (5.1M) | (2.7M) | 1.4M | 4.0M | 685.0K |
| Other Non-Op Income/Expense | (7.1M) | (7.6M) | 5.3M | (3.7M) | 238.0K |
| Non-Operating Income (excl Interest) | 1.1M | 3.0M | (7.2M) | 3.1M | (877.0K) |
| EBT (Pre-Tax Income) | (80.3M) | (78.5M) | (61.3M) | (78.5M) | (87.6M) |
| Income Tax Expense | 578.0K | 512.0K | 1.2M | 486.0K | (136.0K) |
| Bottom Line | |||||
| Net Income | (80.9M) | (79.0M) | (62.5M) | (79.0M) | (87.4M) |
| Earnings from Cont. Ops | (80.9M) | (79.0M) | (62.5M) | (79.0M) | (87.4M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (80.9M) | (79.0M) | (62.5M) | (79.0M) | (87.4M) |
| Per Share | |||||
| Basic EPS | ($1.15) | ($1.17) | ($0.95) | ($1.22) | ($1.36) |
| Diluted EPS | ($1.15) | ($1.17) | ($0.95) | ($1.22) | ($1.36) |
| Revenue Per Share | $1.17 | $1.14 | $0.99 | $0.96 | $0.74 |
| Shares | |||||
| Basic Shares Outstanding | 73.8M | 67.5M | 65.8M | 64.8M | 64.1M |
| Diluted Shares Outstanding | 73.8M | 67.5M | 65.8M | 64.8M | 64.1M |
| Profitability Metrics | |||||
| EBITDA | (65.1M) | (64.4M) | (50.8M) | (69.6M) | (81.4M) |
| D&A | 9.2M | 9.5M | 8.6M | 8.3M | 5.6M |
| EBIT | (74.3M) | (73.9M) | (59.4M) | (77.9M) | (86.9M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026